|
GSK1521498 free base
|
|
1007573-18-3
|
|
GW438014A
|
|
469861-49-2
|
|
Glycycoumarin
|
|
94805-82-0
|
|
(S,S)-GSK321
|
|
1816272-20-4
|
|
GPR4 antagonist 1
|
|
1197879-16-5
|
|
α-Glucosidase-IN-22
|
|
2870693-28-8
|
|
GNE-9278
|
|
2315311-83-0
|
|
Glycyrrhisoflavone
|
|
116709-70-7
|
|
Guaiol
|
|
489-86-1
|
|
Ganoderic acid I
|
|
98665-20-4
|
|
GNE-495
|
|
1449277-10-4
|
|
GRK6-IN-2
|
|
2677786-27-3
|
|
GlyT1 Inhibitor 1
|
|
1820934-93-7
|
|
Gardiquimod diTFA
|
|
1159840-61-5
|
|
gamma-secretase modulator 1
|
|
1172637-87-4
|
|
GW779439X
|
|
551919-98-3
|
|
Glabrone
|
|
60008-02-8
|
|
Gomisin J
|
|
66280-25-9
|
|
Gallopamil hydrochloride
|
|
16662-46-7
|
|
GGTI-2418
|
|
501010-06-6
|
|
GNE-371
|
|
1926986-36-8
|
|
Ganoderic acid C6
|
|
105742-76-5
|
|
GCN2-IN-6
|
|
2183470-09-7
|
|
Guadecitabine sodium
|
|
929904-85-8
|
|
GNE-3511
|
|
1496581-76-0
|
|
GSK2983559 active metabolite
|
|
1423186-80-4
|
|
Groenlandicine
|
|
38691-95-1
|
|
Ginsenoside Rk3
|
|
364779-15-7
|
|
GSK682753A
|
|
1334294-76-6
|
|
GDP366
|
|
501698-03-9
|
|
GS-443902 trisodium
|
|
1355050-21-3
|
|
GSK1379725A
|
|
1802251-00-8
|
|
8-Geranyloxypsoralen
|
|
7437-55-0
|
|
GCPII-IN-1 TFA
|
|
1269794-89-9
|
|
Gentamicin C1a
|
|
26098-04-4
|
|
GLPG2451
|
|
2055015-61-5
|
|
GPR52 antagonist-1
|
|
1239987-91-7
|
|
GLPG0492 (R enantiomer)
|
|
1215085-93-0
|
|
Grazoprevir hydrate
|
|
1350462-55-3
|
|
Glutaminase C-IN-1
|
|
311795-38-7
|
|
Ginkgetin
|
|
481-46-9
|
|
GLP-1(7-36), amide acetate
|
|
1119517-19-9
|
|
G140
|
|
2369751-07-3
|
|
GNE-617 hydrochloride
|
|
2070014-99-0
|
|
Glycyrrhetic acid 3-O-β-D-glucuronide
|
|
34096-83-8
|
|
GNE-502
|
|
1953134-16-1
|
|
Gossypetin
|
|
489-35-0
|
|
GNE-131
|
|
1629063-81-5
|
|
GLUT inhibitor-1
|
|
2421141-40-2
|
|
Gln-AMS
|
|
209543-57-7
|
|
GNE 5729
|
|
2026635-66-3
|
|
GNF179
|
|
1261114-01-5
|
|
GSK2110183 analog 1 hydrochloride
|
|
2070009-64-0
|
|
Glabrescione B
|
|
65893-94-9
|
|
GSK8814
|
|
1997369-78-4
|
|
GW311616
|
|
198062-54-3
|
|
Gemfibrozil 1-O-β-glucuronide
|
|
91683-38-4
|
|
Glucagon receptor antagonists-3
|
|
202917-17-7
|
|
GW284543
|
|
790186-68-4
|
|
GNE-274
|
|
2369048-69-9
|
|
Ginsenoside Rg6
|
|
147419-93-0
|
|
GDC-0834 Racemate
|
|
1133432-46-8
|
|
GNE-272
|
|
1936428-93-1
|
|
Ganoderic acid Y
|
|
86377-52-8
|
|
Glycocyamine-15N,13C2
|
|
2483829-93-0
|
|
GFB-12811
|
|
2775311-17-4
|
|
GW 590735
|
|
343321-96-0
|
|
GSK2256294A
|
|
1142090-23-0
|
|
GNF2133
|
|
2561414-56-8
|
|
GNE-064
|
|
1997321-20-6
|
|
GK187
|
|
1071001-50-7
|
|
GSK 4027
|
|
2079896-25-4
|
|
GDC-2394
|
|
2238822-07-4
|
|
Gliclazide-d4
|
|
1185039-30-8
|
|
Glaucocalyxin A
|
|
79498-31-0
|
|
GPR84 antagonist 8
|
|
1445846-30-9
|
|
GSK4028
|
|
2079886-19-2
|
|
GLP-1(32-36)amide
|
|
1417302-71-6
|
|
GDC-4379
|
|
2252277-73-7
|
|
GNE-207
|
|
2158266-58-9
|
|
GRK5-IN-2
|
|
1642839-27-7
|
|
GLP-1(28-36)amide
|
|
1225021-13-5
|
|
GLPG1205
|
|
1445847-37-9
|
|
Gcase activator 2
|
|
2759897-35-1
|
|
GP531
|
|
142344-87-4
|
|
GKT136901 hydrochloride
|
|
1254507-01-1
|
|
Ganoderic acid D
|
|
108340-60-9
|
|
Genistein 8-c-glucoside
|
|
66026-80-0
|
|
GSK2646264
|
|
1398695-47-0
|
|
GSK3735967
|
|
2170136-86-2
|
|
GRK6-IN-1
|
|
2677786-61-5
|
|
Glucocorticoid receptor agonist-1 Ala-Ala-Mal
|
|
2166376-51-6
|
|
GSK778
|
|
2451862-42-1
|
|
Gypenoside XIII
|
|
80325-22-0
|
|
Gü2602
|
|
1627094-88-5
|
|
GSK143 dihydrochloride
|
|
2341796-81-2
|
|
Gluten Exorphin C
|
|
142479-62-7
|
|
GSK717
|
|
1595278-21-9
|
|
GZD856 formic
|
|
2804039-78-7
|